584 related articles for article (PubMed ID: 25270224)
1. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA inhibits the growth of pancreatic cancer BxPC‑3 cells by decreasing protein expression of TCTP, MCL‑1 and Bcl‑xL.
Huang CY; Chiu TL; Kuo SJ; Chien SY; Chen DR; Su CC
Mol Med Rep; 2013 Mar; 7(3):1045-9. PubMed ID: 23358553
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression.
Cheng CY; Su CC
Int J Mol Med; 2010 Sep; 26(3):379-85. PubMed ID: 20664954
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway.
Su CC
Int J Mol Med; 2018 Apr; 41(4):2389-2396. PubMed ID: 29393362
[TBL] [Abstract][Full Text] [Related]
8. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
Chen YL; Yan MY; Chien SY; Kuo SJ; Chen DR; Cheng CY; Su CC
Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225
[TBL] [Abstract][Full Text] [Related]
9. Influence of Tanshinone IIA on apoptosis of human esophageal carcinoma Eca-109 cells and its molecular mechanism.
Zhang Y; Li S; He H; Han Q; Wang B; Zhu Y
Thorac Cancer; 2017 Jul; 8(4):296-303. PubMed ID: 28407361
[TBL] [Abstract][Full Text] [Related]
10. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of Mcl‑1 and TCTP and increases that of TNF-α and Bax in BxPC‑3 pancreatic carcinoma cells.
Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2013 Jul; 32(1):85-92. PubMed ID: 23652631
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA decreases the migratory ability of AGS cells by decreasing the protein expression of matrix metalloproteinases, nuclear factor κB-p65 and cyclooxygenase-2.
Su CC
Mol Med Rep; 2016 Feb; 13(2):1263-8. PubMed ID: 26648518
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H
Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase‑3 and caspase‑12 in pancreatic cancer BxPC‑3 cell‑derived xenograft tumors.
Chiu TL; Su CC
Mol Med Rep; 2017 May; 15(5):3259-3263. PubMed ID: 28339041
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios.
Su CC; Lin YH
Int J Mol Med; 2008 Sep; 22(3):357-61. PubMed ID: 18698495
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo.
Chien SY; Kuo SJ; Chen YL; Chen DR; Cheng CY; Su CC
Mol Med Rep; 2012 Jan; 5(1):282-6. PubMed ID: 22002472
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential.
Chiu TL; Su CC
Int J Mol Med; 2010 Feb; 25(2):231-6. PubMed ID: 20043132
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of tanshinone IIA on SH-SY5Y cells against oAβ
Yang W; Zhang J; Shi L; Ji S; Yang X; Zhai W; Zong H; Qian Y
Int J Biochem Cell Biol; 2019 Feb; 107():82-91. PubMed ID: 30578955
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells.
Tang C; Xue HL; Huang HB; Wang XG
Neurosci Lett; 2010 Feb; 470(2):126-9. PubMed ID: 20045721
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-alpha in colon cancer cells in vitro and in vivo.
Su CC; Lin YH
Int J Mol Med; 2008 Dec; 22(6):847-51. PubMed ID: 19020785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
